Social Capital Suvretta Holdings Corp IV Cl A (DNAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNAD | CTNM | FBRX | ||
| Company | Social Capital Suvretta Holdings Corp IV Cl A | Contineum Therapeutics Inc | Forte Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.35 | 11.46 | 26.12 | ||
| High | 10.36 | 11.60 | 27.65 | ||
| Low | 10.34 | 11.27 | 24.95 | ||
| Latest | 10.35 | 11.43 | 27.27 | ||
| Change | +0.01 | +0.03 | +1.00 | ||
| % Change | +0.10% | +0.26% | +3.81% | ||
| Volume | 144,200 | 186,900 | 125,400 | ||
| 20-Day Average Volume | 127,825 | 264,910 | 165,970 | ||
| Previous Close | 10.34 | 11.40 | 26.27 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.33 | 11.87 | 24.11 | ||
| 20-Day Raw Stochastic | 83.33% | 32.06% | 71.31% | ||
| 20-Day Relative Strength | 65.52 | 48.95 | 64.25 | ||
| Weighted Alpha | +6.50 | -5.74 | +25.36 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 06/23/23 | -7.15% since 12/23/25 | +2.35% since 12/23/25 | ||
| Low | 10.33 on 06/28/23 | 11.27 on 12/31/25 | 24.78 on 12/26/25 | ||
| High | 10.36 on 06/30/23 | 12.95 on 12/24/25 | 29.33 on 12/29/25 | ||
| 1-Month | |||||
| %Chg | +0.38% since 05/30/23 | +3.25% since 11/28/25 | +46.93% since 11/28/25 | ||
| Low | 10.30 on 06/01/23 | 10.42 on 12/01/25 | 17.33 on 12/03/25 | ||
| High | 10.36 on 06/30/23 | 13.48 on 12/11/25 | 31.27 on 12/22/25 | ||
| 3-Month | |||||
| %Chg | +1.27% since 03/30/23 | -2.72% since 09/30/25 | +81.80% since 09/30/25 | ||
| Low | 10.22 on 04/10/23 | 10.07 on 11/07/25 | 10.30 on 11/05/25 | ||
| High | 10.46 on 04/12/23 | 13.48 on 12/11/25 | 31.27 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | +2.99% since 12/30/22 | +187.91% since 06/30/25 | +110.90% since 06/30/25 | ||
| Low | 10.04 on 01/04/23 | 3.72 on 07/16/25 | 9.10 on 08/06/25 | ||
| High | 10.92 on 01/12/23 | 13.49 on 09/19/25 | 31.27 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 330,061 | 332,686 | 329,084 | ||
| Shares Outstanding, K | 31,890 | 29,183 | 12,527 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 2,740,000 | -42,260,000 | -35,480,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | 2,460,000 | -12,790,000 | -17,680,000 | ||
| 60-Month Beta | 0.01 | 1.25 | 3.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/15/23 | -0.45 on 10/30/25 | -0.99 on 11/14/25 | ||
| Latest Earnings Date | 01/01/70 | 03/05/26 | 03/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||